NEW YORK (GenomeWeb News) – Bioinformatics company Eureka Genomics has reeled in a $750,000 Phase II Small Business Innovation Research grant from the Department of Homeland Security to continue to develop tools to detect rare variants of the anthrax pathogen Bacillus anthracis.
Houston-based Eureka is a private firm that develops next-generation sequencing analysis tools for use in discovering microorganisms associated with disease. It also provides sequencing and analysis services.
Full Story On Genome Daily News
- Now, suitcase-sized device to detect anthrax (news.bioscholar.com)
- Future Environment Designs sponsors Bacillus anthracis and Anthrax Video (futureenv.blogspot.com)
- Nanotechnology detector for deadly anthrax (nanowerk.com)
- Will the Cloud Save Genomics? [Mike the Mad Biologist] (scienceblogs.com)